Changes of Coagulation and Fibrinolytic Function in Elderly Patients with Essential Hypertension and Diabetes

WANG Lili,XIAO Guanghui,CHEN Yiling,DU Weijing
DOI: https://doi.org/10.3969/j.issn.0253-9896.2012.02.016
2012-01-01
Abstract:Objective:To investigate the coagulation and fibrinolysis changes in elderly patients with essential hyperten sion and type 2 diabetes. Methods:There were three groups in this study, 50 patients with essential hypertension (hyperten sion group) , 50 patients with essential hypertension and type 2 diabetes (hypertension + diabetes group) and 30 healthy con trol subjects (control group). Plasma levels of von Willebrand’s factor (vWF), fibrinogen (Fbg), prothombin fragment 1+2 (F1+ 2), tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) were detected in three groups. Val ues of blood pressures and blood lipids were also detected and compared between three groups. Results:The plasma levels of vWF, Fbg, F1+2, t-PA and PAI-1 were significantly different between three groups (P < 0.01). The values of vWF, Fbg, F1+ 2 and PAI-1 were significantly higher in hypertension + diabetes group than those of control group. But the level of t-PA was lower in hypertension + diabetes group than that of control group (P < 0.05). There were significantly higher levels of F1+2 and PAI-1, but significantly lower level of t-PA, in hypertension + diabetes group than those of hypertension group (P < 0.05 or P < 0.01). Conclusion:There are coagulation and fibrinolysis disturbances in elderly patients with both essential hyper tension and type 2 diabetes. Molecular markers should be measured in those patients for prevention and treatment of thrombot ic diseases.
What problem does this paper attempt to address?